Rezolute, Inc. (NASDAQ:RZLT – Get Rating) was the recipient of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 58,500 shares, a drop of 23.5% from the May 15th total of 76,500 shares. Based on an average trading volume of 212,400 shares, the days-to-cover […]
Analysts forecast that Nektar Therapeutics (NASDAQ:NKTR – Get Rating) will announce $22.96 million in sales for the current quarter, according to Zacks. Six analysts have issued estimates for Nektar Therapeutics’ earnings, with estimates ranging from $21.10 million to $26.25 million. Nektar Therapeutics reported sales of $28.33 million in the same quarter last year, which would […]
Rezolute (NASDAQ:RZLT – Get Rating)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a report issued on Monday, TipRanks reports. They currently have a $21.00 price objective on the stock. A number of other equities research analysts also recently commented on the stock. Roth Capital lifted their target price on […]
Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Rating) have been given a consensus rating of “Hold” by the fifteen brokerages that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and four have issued a buy recommendation on the company. […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.